TABLE 1  FDA-approved in vitro Emergency Use Authorization diagnostics available for SARS-CoV-2 as of 30 March 2020a
Developer  Diagnostic platform
Centers for Disease Control and Prevention (CDC)  CDC 2019-nCoV real-time RT-PCR diagnostic panel
Wadsworth Center, New York State Department of Public Health (CDC)  New York SARS-CoV-2 real-time reverse transcriptase (RT)-PCR diagnostic panel
Roche Molecular Systems, Inc. (RMS)  cobas SARS-CoV-2
Thermo Fisher Scientific, Inc.  TaqPath COVID-19 combo kit
Laboratory Corporation of America (LabCorp)  COVID-19 RT-PCR test
Hologic, Inc.  Panther fusion SARS-CoV-2
Quest Diagnostics Infectious Disease, Inc.  Quest SARS-CoV-2 rRT-PCR
Quidel Corporation  Lyra SARS-CoV-2 assay
Abbott Molecular  Abbott RealTime SARS-CoV-2 assay
GenMark Diagnostics, Inc.  ePlex SARS-CoV-2 test
DiaSorin Molecular, LLC  Simplexa COVID-19 direct assay
Cepheid  Xpert Xpress SARS-CoV-2 test
Primerdesign, Ltd.  COVID-19 Genesig real-time PCR assay
Mesa Biotech, Inc.  Accula SARS-Cov-2 test
BioFire Defense, LLC  BioFire COVID-19 test
PerkinElmer, Inc.  PerkinElmer new coronavirus nucleic acid detection kit
Avellino Lab USA, Inc.  AvellinoCoV2 test
BGI Genomics, Co. Ltd.  Real-time fluorescent RT-PCR kit for detecting SARS-2019-nCoV
Luminex Molecular Diagnostics, Inc.  NxTAG CoV extended panel assay
Abbott Diagnostics Scarborough, Inc.  ID Now COVID-19
Qiagen GmbH  QIAstat-Dx respiratory SARS-CoV-2 panel
NeuMoDx Molecular, Inc.  NeuMoDx SARS-CoV-2 assay
a  Data are from references 258 and 259.